AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33629100 — intervention group
Group type: COMPARATOR
Intervention: Epoetin alfa
Number of subjects: 1043
Study 32726105 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazarotene 0.045% lotion
Number of subjects: 1614
Study 32726105 — intervention group
Group type: COMPARATOR
Intervention: Vehicle lotion
Number of subjects: 1614
Study 35568193 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial sensing ON
Number of subjects: 640
Study 35568193 — intervention group
Group type: COMPARATOR
Intervention: Atrial sensing OFF
Number of subjects: 640
Study 34689745 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized birthing room intervention
Number of subjects: 0
Study 34689745 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 33095032 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 3730
Study 35759365 — intervention group
Group type: EXPERIMENTAL
Intervention: Teens Taking Charge Cancer web-based self-management program
Number of subjects: 81
Study 35759365 — intervention group
Group type: COMPARATOR
Intervention: Control group (education with links to 12 general cancer websites)
Number of subjects: 81
Study 34769960 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous therapeutic ultrasound (CUS; at 0.4 W/cm2)
Number of subjects: 10
Study 34769960 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed therapeutic ultrasound (PUS; at 20% duty cycle, 0.08 W/cm2)
Number of subjects: 10
Study 34769960 — intervention group
Group type: COMPARATOR
Intervention: Placebo (equipment on, no energy provided)
Number of subjects: 10
Study 36330051 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene Blue (MB) injection
Number of subjects: 162
Study 36330051 — intervention group
Group type: COMPARATOR
Intervention: Control (standard pathological work-up)
Number of subjects: 162
Study 34534517 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary daily lateral flow device (LFD) testing for 7 days with LFD-negative contacts remaining at school
Number of subjects: 201
Study 34534517 — intervention group
Group type: COMPARATOR
Intervention: Self-isolation of school-based COVID-19 contacts for 10 days
Number of subjects: 201
Study 32270638 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic‐sacral tendon‐regulation needling technique of acupuncture combined with manipulative reduction
Number of subjects: 80
Study 32270638 — intervention group
Group type: COMPARATOR
Intervention: Simple manipulative therapy
Number of subjects: 80
Study 36148467 — intervention group
Group type: EXPERIMENTAL
Intervention: Avidekel oil (30% cannabidiol and 1% tetrahydrocannabinol: 295 mg and 12.5 mg per ml)
Number of subjects: 60
Study 36148467 — intervention group
Group type: COMPARATOR
Intervention: Placebo oil
Number of subjects: 60
Study 32756556 — intervention group
Group type: EXPERIMENTAL
Intervention: SRL
Number of subjects: 71
Study 32756556 — intervention group
Group type: COMPARATOR
Intervention: CsA
Number of subjects: 71
Study 32224728 — intervention group
Group type: EXPERIMENTAL
Intervention: Video assessment tool for 2-stage esophagectomy
Number of subjects: 0
Study 32224728 — intervention group
Group type: EXPERIMENTAL
Intervention: Photographic assessment tool for 2-stage esophagectomy
Number of subjects: 0
Study 34243808 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered mirror therapy (MT) education in addition to regular rehabilitation interventions for 4 weeks
Number of subjects: 36
Study 34243808 — intervention group
Group type: COMPARATOR
Intervention: Regular rehabilitation interventions
Number of subjects: 36
Study 35380419 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric pyrophosphate citrate (FPC) administered as a single intravenous dose of 6.5 mg to healthy subjects.
Number of subjects: 26
Study 35380419 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric pyrophosphate citrate (FPC) administered at two sequential hemodialysis treatments: HD dose 1 (27.2 mg at 95 μg/L for 4 h) and HD dose 2 (6.5 mg via pre-dialyzer blood circuit).
Number of subjects: 26
Study 35380419 — intervention group
Group type: COMPARATOR
Intervention: Comparison of PK parameters between HD dose 1 and HD dose 2.
Number of subjects: 26
Study 35380419 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety profile of FPC in both groups.
Number of subjects: 26
Study 34196445 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized depression risk information
Number of subjects: 712
Study 34196445 — intervention group
Group type: COMPARATOR
Intervention: Control group (no personalized risk information)
Number of subjects: 712
Study 32560739 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 g of active ZHWFG three times daily
Number of subjects: 216
Study 32560739 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g of active ZHWFG plus 5 g of ZHWFG‐matched placebo three times daily
Number of subjects: 216
Study 32560739 — intervention group
Group type: COMPARATOR
Intervention: 15 g of ZHWFG‐matched placebo three times daily
Number of subjects: 216
Study 35409525 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-day stress management training program and another half‐day booster after four and six months
Number of subjects: 174
Study 35409525 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 174
Study 33975149 — intervention group
Group type: EXPERIMENTAL
Intervention: Two nights of sleep disruption
Number of subjects: 79
Study 33975149 — intervention group
Group type: COMPARATOR
Intervention: Two nights of uninterrupted sleep
Number of subjects: 79
Study 34406911 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvanted recombinant zoster vaccine (RZV)
Number of subjects: 1846
Study 34406911 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1846
Study 32444133 — intervention group
Group type: EXPERIMENTAL
Intervention: Eswab scraping with Amies transport medium
Number of subjects: 40
Study 32444133 — intervention group
Group type: COMPARATOR
Intervention: 23‐gauge needle scraping in BACTEC Peds broth
Number of subjects: 40
Study 32444133 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined methods
Number of subjects: 40
Study 32444133 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle scraping first
Number of subjects: 40
Study 32444133 — intervention group
Group type: EXPERIMENTAL
Intervention: Eswab method
Number of subjects: 40
Study 33771081 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic caffeine
Number of subjects: 181
Study 33771081 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic caffeine
Number of subjects: 181
Study 33876784 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural blockade with 0, 50, 100 or 150 mg of epidural ropivacaine
Number of subjects: 28
Study 33876784 — intervention group
Group type: COMPARATOR
Intervention: Propofol at concentrations up to 6 μg ml-1
Number of subjects: 28
Study 33876784 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of epidural anaesthesia and intravenous propofol
Number of subjects: 28
Study 33876784 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural blockade
Number of subjects: 28
Study 33586626 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial Aqualizer™ therapy (Group 1)
Number of subjects: 53
Study 33586626 — intervention group
Group type: COMPARATOR
Intervention: No initial therapy (Group 2)
Number of subjects: 53
Study 35560319 — intervention group
Group type: EXPERIMENTAL
Intervention: Coca Cola (blind condition)
Number of subjects: 25
Study 35560319 — intervention group
Group type: EXPERIMENTAL
Intervention: Cola beverage (blind condition)
Number of subjects: 25
Study 35560319 — intervention group
Group type: EXPERIMENTAL
Intervention: Coca Cola (not blind condition)
Number of subjects: 25
Study 35560319 — intervention group
Group type: EXPERIMENTAL
Intervention: Cola beverage (not blind condition)
Number of subjects: 25
Study 35560319 — intervention group
Group type: COMPARATOR
Intervention: Brand knowledge (not blind condition)
Number of subjects: 25
Study 35560319 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference change from blind to not blind conditions
Number of subjects: 25
Study 35560319 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiological response (blind vs not blind)
Number of subjects: 25
Study 35560319 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumer vs non-consumer of Coca-Cola
Number of subjects: 25
Study 34517140 — intervention group
Group type: EXPERIMENTAL
Intervention: Normoxemia (FIO2 titrated to oxygen saturation of 95-98%)
Number of subjects: 106
Study 34517140 — intervention group
Group type: COMPARATOR
Intervention: Hyperoxia (FIO2 = 0.8)
Number of subjects: 106
Study 33872554 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 0
Study 33872554 — intervention group
Group type: EXPERIMENTAL
Intervention: Dutasteride
Number of subjects: 0
Study 32448382 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrice daily Biphasic Human Insulin 30 (BHI 30)
Number of subjects: 22
Study 32448382 — intervention group
Group type: COMPARATOR
Intervention: Twice daily Biphasic Human Insulin 30 (BHI 30)
Number of subjects: 22
Study 35705982 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality technology
Number of subjects: 50
Study 35705982 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional teaching methods)
Number of subjects: 50
Study 33065208 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga (n = 30)
Number of subjects: 48
Study 33065208 — intervention group
Group type: COMPARATOR
Intervention: Support group (n = 18)
Number of subjects: 48
Study 35430718 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized capsaicin (AC), 1-10 drops of liquid cayenne extract (1.5-2% capsaicin) in 100 mL carbonated water.
Number of subjects: 60
Study 33275318 — intervention group
Group type: EXPERIMENTAL
Intervention: Imeglimin 500 mg
Number of subjects: 299
Study 33275318 — intervention group
Group type: EXPERIMENTAL
Intervention: Imeglimin 1000 mg
Number of subjects: 299
Study 33275318 — intervention group
Group type: EXPERIMENTAL
Intervention: Imeglimin 1500 mg
Number of subjects: 299
Study 33275318 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 299
Study 32400903 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy (CBT) adapted for SE-AN
Number of subjects: 0
Study 32400903 — intervention group
Group type: COMPARATOR
Intervention: Enhanced cognitive behavioral therapy (CBT-E)
Number of subjects: 0
Study 35940478 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy + gastrocnemius vibration (FV_GM)
Number of subjects: 64
Study 35940478 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy + tibialis anterior vibration (FV_TA)
Number of subjects: 64
Study 33571026 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgolide plus aspirin
Number of subjects: 0
Study 33571026 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus aspirin
Number of subjects: 0
Study 32988524 — intervention group
Group type: COMPARATOR
Intervention: Basal diet (2,000 IU vitamin D3)
Number of subjects: 240
Study 32988524 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet supplemented with 3 ppm Cx and 34.5 μg 25-OH-D3
Number of subjects: 240
Study 32988524 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet supplemented with 6 ppm Cx and 69 μg 25-OH-D3
Number of subjects: 240
Study 32988524 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet supplemented with 9 ppm Cx and 103.5 μg 25-OH-D3
Number of subjects: 240
Study 32988524 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet supplemented with 12 ppm Cx and 138 μg 25-OH-D3
Number of subjects: 240
Study 32988524 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet supplemented with varying levels of Cx and 25-OH-D3
Number of subjects: 240
Study 35830338 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Intensity Shock Wave Therapy (LiST)
Number of subjects: 70
Study 35830338 — intervention group
Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 70
Study 33546941 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralose
Number of subjects: 20
Study 33546941 — intervention group
Group type: EXPERIMENTAL
Intervention: Stevia
Number of subjects: 20
Study 33546941 — intervention group
Group type: COMPARATOR
Intervention: Sucrose
Number of subjects: 20
Study 32085823 — intervention group
Group type: EXPERIMENTAL
Intervention: ART plus vorinostat and T-cell inducing vaccines (ART + V + V)
Number of subjects: 60
Study 32085823 — intervention group
Group type: COMPARATOR
Intervention: ART-only
Number of subjects: 60
Study 33006288 — intervention group
Group type: EXPERIMENTAL
Intervention: VIA-IS
Number of subjects: 26
Study 33006288 — intervention group
Group type: COMPARATOR
Intervention: Control group (goal-setting as usual)
Number of subjects: 26
Study 34178828 — intervention group
Group type: EXPERIMENTAL
Intervention: Drinking 1 liter of water per day before each main meal (PW group)
Number of subjects: 40
Study 34178828 — intervention group
Group type: COMPARATOR
Intervention: No water consumption before any meal (NPW group)
Number of subjects: 40
Study 35194169 — intervention group
Group type: COMPARATOR
Intervention: Cervical collars (c-collars)
Number of subjects: 30
Study 35194169 — intervention group
Group type: EXPERIMENTAL
Intervention: Folded towels
Number of subjects: 30
Study 35194169 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam neck braces
Number of subjects: 30
Study 32475440 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g C. lanatus essential oil/kg feed (1gCL)
Number of subjects: 72
Study 32475440 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g C. lanatus essential oil/kg feed (2gCL)
Number of subjects: 72
Study 32475440 — intervention group
Group type: EXPERIMENTAL
Intervention: C. lanatus essential oils in diets
Number of subjects: 72
Study 34477812 — intervention group
Group type: EXPERIMENTAL
Intervention: MCI Gel
Number of subjects: 25
Study 34477812 — intervention group
Group type: COMPARATOR
Intervention: Cheese
Number of subjects: 25
Study 34477812 — intervention group
Group type: COMPARATOR
Intervention: Hom. Cheese
Number of subjects: 25
Study 34477812 — intervention group
Group type: EXPERIMENTAL
Intervention: MCI Drink
Number of subjects: 25
Study 34716530 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted rank test for comparing marginal survival distributions between intervention arms
Number of subjects: 0
Study 34716530 — intervention group
Group type: EXPERIMENTAL
Intervention: Sample size calculation method
Number of subjects: 0
Study 33313858 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phone-based support in addition to usual care
Number of subjects: 75
Study 33313858 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 75
Study 34068089 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-set Resistance Training (1-RT)
Number of subjects: 118
Study 34068089 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-set Resistance Training (3-RT)
Number of subjects: 118
Study 34068089 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole Body Electromyostimulation (WB-EMS)
Number of subjects: 118
Study 34068089 — intervention group
Group type: COMPARATOR
Intervention: Inactive Control Group (CON)
Number of subjects: 118
Study 32654897 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery (gastric bypass, vertical banded gastroplasty, gastric banding)
Number of subjects: 3597
Study 32654897 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 3597
Study 32654897 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 3597
Study 35322637 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized treatment (basic treatment, Qiming granules, individualized Chinese herbal medicines)
Number of subjects: 140
Study 35322637 — intervention group
Group type: COMPARATOR
Intervention: Stationary treatment (basic treatment and Qiming granules)
Number of subjects: 140
Study 32880495 — intervention group
Group type: EXPERIMENTAL
Intervention: Selumetinib (75 mg twice a day) in combination with docetaxel
Number of subjects: 0
Study 32880495 — intervention group
Group type: COMPARATOR
Intervention: Selumetinib (monotherapy)
Number of subjects: 0
Study 32880495 — intervention group
Group type: EXPERIMENTAL
Intervention: Selumetinib (in combination with docetaxel)
Number of subjects: 0
Study 33610365 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal medical therapy (combination of 4 drugs: ACE inhibitor or ARB, beta-blocker, statin, and 1 antiplatelet drug)
Number of subjects: 1212
Study 33610365 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal medical therapy
Number of subjects: 1212
Study 33610365 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting with medical therapy
Number of subjects: 1212
Study 33610365 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 1212
Study 33514272 — intervention group
Group type: COMPARATOR
Intervention: Egocentric task (free-trunk condition)
Number of subjects: 0
Study 33514272 — intervention group
Group type: COMPARATOR
Intervention: Egocentric task (blocked-trunk condition)
Number of subjects: 0
Study 33514272 — intervention group
Group type: COMPARATOR
Intervention: Exocentric task (free-trunk condition)
Number of subjects: 0
Study 33514272 — intervention group
Group type: COMPARATOR
Intervention: Exocentric task (blocked-trunk condition)
Number of subjects: 0
Study 33514272 — intervention group
Group type: EXPERIMENTAL
Intervention: Exocentric movement after stroke
Number of subjects: 0
Study 36350714 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimonthly cash transfers and nutrition education
Number of subjects: 599
Study 36350714 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimonthly cash transfers alone
Number of subjects: 599
Study 36350714 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 599
Study 32030023 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 48
Study 32030023 — intervention group
Group type: COMPARATOR
Intervention: Care as Usual
Number of subjects: 48
Study 35935311 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic Regression (LR) classifier
Number of subjects: 150
Study 35935311 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear Discriminant (LD) classifier
Number of subjects: 150
Study 35935311 — intervention group
Group type: COMPARATOR
Intervention: Group B1 (metastasis within 0.5 years)
Number of subjects: 150
Study 35935311 — intervention group
Group type: COMPARATOR
Intervention: Group B2 (metastasis within 0.5-1.0 years)
Number of subjects: 150
Study 35935311 — intervention group
Group type: COMPARATOR
Intervention: Group B3 (metastasis within 1.0-2.0 years)
Number of subjects: 150
Study 35935311 — intervention group
Group type: EXPERIMENTAL
Intervention: Texture features of CT images based on AI algorithms
Number of subjects: 150
Study 34432302 — intervention group
Group type: EXPERIMENTAL
Intervention: PAS-calcium formulation (PAS-Ca)
Number of subjects: 0
Study 34402789 — intervention group
Group type: EXPERIMENTAL
Intervention: Both compounds
Number of subjects: 47
Study 33256420 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic tattooing with two injection points and 1 ml of labeling volume
Number of subjects: 195
Study 33256420 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic tattooing with three injection points and 1.5 ml of labeling volume
Number of subjects: 195
Study 33256420 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic tattooing with two injection points and 1.5 ml of labeling volume
Number of subjects: 195
Study 33256420 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic tattooing with three injection points and 1 ml of labeling volume
Number of subjects: 195
Study 32230754 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra virgin olive oil (EVOO), 50 mL daily for 3 weeks
Number of subjects: 30
Study 32230754 — intervention group
Group type: COMPARATOR
Intervention: Refined olive oil (ROO), 50 mL daily for 3 weeks
Number of subjects: 30
Study 32230754 — intervention group
Group type: COMPARATOR
Intervention: Comparison between EVOO and ROO
Number of subjects: 30
Study 35899379 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 115
Study 35899379 — intervention group
Group type: COMPARATOR
Intervention: Health enhancement program (HEP)
Number of subjects: 115
Study 35899379 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term meditators
Number of subjects: 115
Study 34131924 — intervention group
Group type: EXPERIMENTAL
Intervention: AOG‐3DP (3D printed access opening guide)
Number of subjects: 90
Study 34131924 — intervention group
Group type: COMPARATOR
Intervention: Control (no aid)
Number of subjects: 90
Study 32057982 — intervention group
Group type: EXPERIMENTAL
Intervention: Knotless all‐suture anchors
Number of subjects: 30
Study 32057982 — intervention group
Group type: COMPARATOR
Intervention: Knotted all‐suture anchors
Number of subjects: 30
Study 32057982 — intervention group
Group type: COMPARATOR
Intervention: Simple stitch configuration
Number of subjects: 30
Study 32057982 — intervention group
Group type: EXPERIMENTAL
Intervention: Mattress stitch configuration
Number of subjects: 30
Study 32057982 — intervention group
Group type: EXPERIMENTAL
Intervention: Knotless anchors with simple stitch techniques
Number of subjects: 30
Study 32057982 — intervention group
Group type: EXPERIMENTAL
Intervention: Knotless-mattress configuration
Number of subjects: 30
Study 32057982 — intervention group
Group type: EXPERIMENTAL
Intervention: Knotless anchors
Number of subjects: 30
Study 33851518 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampicin 600 mg daily for a week
Number of subjects: 0
Study 33851518 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampicin treatment
Number of subjects: 0
Study 33851518 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33616314 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenvatinib plus Pembrolizumab
Number of subjects: 1069
Study 33616314 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenvatinib plus Everolimus
Number of subjects: 1069
Study 33616314 — intervention group
Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 1069
Study 32333325 — intervention group
Group type: EXPERIMENTAL
Intervention: Selonsertib (1, 3, 10, 30, or 100 mg)
Number of subjects: 107
Study 32333325 — intervention group
Group type: EXPERIMENTAL
Intervention: Selonsertib (various doses)
Number of subjects: 107
Study 32333325 — intervention group
Group type: EXPERIMENTAL
Intervention: Selonsertib
Number of subjects: 107
Study 32333325 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 36195927 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioactive glass (BAG) 45S5 paste
Number of subjects: 24